The carbapenem family.
作者信息
Basker M J
出版信息
J Antimicrob Chemother. 1982 Jul;10(1):4-7. doi: 10.1093/jac/10.1.4.
PMID:6980875
Abstract
摘要
相似文献
1
The carbapenem family.碳青霉烯类家族。
J Antimicrob Chemother. 1982 Jul;10(1):4-7. doi: 10.1093/jac/10.1.4.
2
[Role of beta-lactamase inhibitors in the etiotropic therapy of infectious diseases].[β-内酰胺酶抑制剂在感染性疾病特效治疗中的作用]
Antibiot Khimioter. 1993 Apr-May;38(4-5):63-70.
3
[Clinical significance of beta-lactamase inhibitors].β-内酰胺酶抑制剂的临床意义
Klin Wochenschr. 1988 Jan 15;66(2):81-3. doi: 10.1007/BF01713017.
4
New β-lactam antibiotics and β-lactamase inhibitors.新型β-内酰胺类抗生素和β-内酰胺酶抑制剂。
Expert Opin Ther Pat. 2010 Oct;20(10):1277-93. doi: 10.1517/13543776.2010.515588.
5
[Uses in in ambulatory and stationary situations. Clinical indications for beta lactams].
Pharm Unserer Zeit. 2006;35(5):428-31. doi: 10.1002/pauz.200600189.
6
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?新型β-内酰胺/β-内酰胺酶抑制剂头孢洛扎/他唑巴坦和头孢他啶/阿维巴坦的作用是什么？
Expert Rev Anti Infect Ther. 2016 Oct;14(10):875-8. doi: 10.1080/14787210.2016.1233060.
7
[Betalactams in clinical practice].[临床实践中的β-内酰胺类抗生素]
Rev Esp Quimioter. 2015 Feb;28(1):1-9.
8
Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?重症患者β-内酰胺类药物的治疗药物监测：有无必要？
Int J Antimicrob Agents. 2010 May;35(5):419-20. doi: 10.1016/j.ijantimicag.2010.01.022. Epub 2010 Mar 1.
9
Are prolonged/continuous infusions of β-lactams for all?β-内酰胺类药物都需要长时间/持续输注吗？
Clin Infect Dis. 2013 Jul;57(2):323. doi: 10.1093/cid/cit200. Epub 2013 Apr 1.
10
Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India.用于耐多药革兰氏阴性菌感染的新型β-内酰胺/β-内酰胺酶抑制剂：印度面临的挑战、影响及监测策略
Indian J Med Microbiol. 2018 Jul-Sep;36(3):334-343. doi: 10.4103/ijmm.IJMM_18_326.
引用本文的文献
1
Carbapenems: past, present, and future.碳青霉烯类抗生素：过去、现在和未来。
Antimicrob Agents Chemother. 2011 Nov;55(11):4943-60. doi: 10.1128/AAC.00296-11. Epub 2011 Aug 22.
2
In vitro and pharmacokinetic properties of the carbapenems.碳青霉烯类药物的体外及药代动力学特性。
Antimicrob Agents Chemother. 1986 Sep;30(3):343-9. doi: 10.1128/AAC.30.3.343.
3
[Clinical significance of beta-lactamase inhibitors].β-内酰胺酶抑制剂的临床意义
Klin Wochenschr. 1988 Jan 15;66(2):81-3. doi: 10.1007/BF01713017.
Zotero 插件